NYSE:GLOBIT
Globant Taps AI Cancer Research And Payments Deals As Shares Lag Targets
Globant (NYSE:GLOB) announced an AI focused collaboration with PharmaMar to support cancer drug discovery efforts.
The company also agreed a global integration partnership with payments platform Adyen for enterprise clients.
Both arrangements position Globant in healthcare and fintech projects tied to drug research and digital payments infrastructure.
Globant operates as a digital services and technology company, working with enterprises that are investing in cloud, data and AI based...